By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Capsalus today said it has signed a letter of intent to buy the marketing rights and assets of GeneWize Life Sciences for an undisclosed amount.

GeneWize is the wholly-owned direct-selling subsidiary of consumer genomics firm GeneLink Biosciences and provides DNA customized nutritional supplements, skin care, and gene modulating weight management products.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.